Detection of Microhemorrhage in Posterior Reversible Encephalopathy Syndrome Using Susceptibility-Weighted Imaging

References

1. 1.↵
   1. Hinchey J,
   2. Chaves C,
   3. Appignani B,
   4. et al

   . A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500

   CrossRefPubMedWeb of Science
2. 2.↵
   1. McKinney AM,
   2. Short J,
   3. Truwit CL,
   4. et al

   . Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904–12

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Casey SO,
   2. Sampaio RC,
   3. Michel E,
   4. et al

   . Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21:1199–206

   Abstract/FREE Full Text
4. 4.↵
   1. Schwartz RB,
   2. Bravo SM,
   3. Klufas RA,
   4. et al

   . Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627–31

   CrossRefPubMedWeb of Science
5. 5.↵
   1. McKinney AM,
   2. Kieffer SA,
   3. Paylor RT,
   4. et al

   . Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR Am J Roentgenol 2009;193:192–206

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Hauser RA,
   2. Lacey DM,
   3. Knight MR

   . Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 1988;45:1078–83

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Schwartz RB,
   2. Feske SK,
   3. Polak JF,
   4. et al

   . Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000;217:371–76

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Schwaighofer BW,
   2. Hesselink JR,
   3. Healy ME

   . MR demonstration of reversible brain abnormalities in eclampsia. J Comput Assist Tomogr 1989;13:310–12

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Raroque HG Jr.,
   2. Orrison WW,
   3. Rosenberg GA

   . Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neurology 1990;40:167–69

   Abstract/FREE Full Text
10. 10.↵
    1. Truwit CL,
    2. Denaro CP,
    3. Lake JR,
    4. et al

    . MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651–59

    Abstract/FREE Full Text
11. 11.↵
    1. Hefzy HM,
    2. Bartynski WS,
    3. Boardman JF,
    4. et al

    . Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol 2009;30:1371–79

    Abstract/FREE Full Text
12. 12.↵
    1. Tong KA,
    2. Ashwal S,
    3. Holshouser BA,
    4. et al

    . Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol 2004;56:36–50

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Tong KA,
    2. Ashwal S,
    3. Holshouser BA,
    4. et al

    . Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003;227:332–39

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Wycliffe ND,
    2. Choe J,
    3. Holshouser B,
    4. et al

    . Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography: a retrospective study. J Magn Reson Imaging 2004;20:372–77

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Pinker K,
    2. Stavrou I,
    3. Szomolanyi P,
    4. et al

    . Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings—preliminary results. Invest Radiol 2007;42:346–51

    CrossRefPubMed
16. 16.↵
    1. Nandigam RN,
    2. Viswanathan A,
    3. Delgado P,
    4. et al

    . MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 2009;30:338–43

    Abstract/FREE Full Text
17. 17.↵
    1. Gao T,
    2. Wang Y,
    3. Zhang Z

    . Silent cerebral microbleeds on susceptibility-weighted imaging of patients with ischemic stroke and leukoaraiosis. Neurol Res 2008;30:272–76

    CrossRefPubMed
18. 18.↵
    1. Colbert CA,
    2. Holshouser BA,
    3. Aaen GS,
    4. et al

    . Value of cerebral microhemorrhages detected with susceptibility-weighted MR imaging for prediction of long-term outcome in children with nonaccidental trauma. Radiology 2010;256:898–905

    CrossRefPubMed
19. 19.↵
    1. de Seze J,
    2. Mastain B,
    3. Stojkovic T,
    4. et al

    . Unusual MR findings of the brain stem in arterial hypertension. AJNR Am J Neuroradiol 2000;21:391–94

    Abstract/FREE Full Text
20. 20.↵
    1. Chang GY,
    2. Keane JR

    . Hypertensive brainstem encephalopathy: three cases presenting with severe brainstem edema. Neurology 1999;53:652–54

    FREE Full Text
21. 21.↵
    1. Pfefferbaum A,
    2. Adalsteinsson E,
    3. Rohlfing T,
    4. et al

    . MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 2009;47:493–500

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Haacke EM,
    2. Xu Y,
    3. Cheng YC,
    4. et al

    . Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–18

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Hartwigsen G,
    2. Siebner HR,
    3. Deuschl G,
    4. et al

    . Incidental findings are frequent in young healthy individuals undergoing magnetic resonance imaging in brain research imaging studies: a prospective single-center study. J Comput Assist Tomogr 2010;34:596–600

    CrossRefPubMed
24. 24.↵
    1. Wu Z,
    2. Li S,
    3. Lei J,
    4. et al

    . Evaluation of traumatic subarachnoid hemorrhage using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2010;31:1302–10

    Abstract/FREE Full Text
25. 25.↵
    1. Wu Z,
    2. Mittal S,
    3. Kish K,
    4. et al

    . Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging 2009;29:177–82

    CrossRefPubMed
26. 26.↵
    1. Reichenbach JR,
    2. Venkatesan R,
    3. Schillinger DJ,
    4. et al

    . Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272–77

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Haacke EM,
    2. Makki M,
    3. Ge Y,
    4. et al

    . Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29:537–44

    CrossRefPubMed
28. 28.↵
    1. Kim HS,
    2. Jahng GH,
    3. Ryu CW,
    4. et al.

    Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 2009;30:1574–79

    Abstract/FREE Full Text
29. 29.↵
    1. Haacke EM,
    2. DelProposto ZS,
    3. Chaturvedi S,
    4. et al

    . Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. AJNR Am J Neuroradiol 2007;28:316–17

    Abstract/FREE Full Text
30. 30.↵
    1. Lee BC,
    2. Vo KD,
    3. Kido DK,
    4. et al

    . MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol 1999;20:1239–42

    Abstract/FREE Full Text
31. 31.↵
    1. Aranas RM,
    2. Prabhakaran S,
    3. Lee VH

    . Posterior reversible encephalopathy syndrome associated with hemorrhage. Neurocrit Care 2009;10:306–12

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Bartynski WS

    . Posterior reversible encephalopathy syndrome. Part 2. Controversies surrounding pathophysiology of vasogenic edema.. AJNR Am J Neuroradiol 2008;29:1043–49

    Abstract/FREE Full Text
33. 33.↵
    1. Auer LM

    . The pathogenesis of hypertensive encephalopathy: experimental data and their clinical relevance with special reference to neurosurgical patients. Acta Neurochir Suppl (Wien) 1978;27:1–111

    PubMed
34. 34.↵
    1. Kontos HA,
    2. Wei EP,
    3. Navari RM,
    4. et al

    . Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978;234:H371–83

    PubMedWeb of Science
35. 35.↵
    1. MacKenzie ET,
    2. Strandgaard S,
    3. Graham DI,
    4. et al

    . Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res 1976;39:33–41

    Abstract/FREE Full Text
36. 36.↵
    1. Striano P,
    2. Striano S,
    3. Tortora F,
    4. et al

    . Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit 2005;11:CR549–53

    PubMedWeb of Science
37. 37.↵
    1. Brubaker LM,
    2. Smith JK,
    3. Lee YZ,
    4. et al.

    Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol 2005;26:825–30

    Abstract/FREE Full Text
38. 38.↵
    1. Naidu K,
    2. Moodley J,
    3. Corr P,
    4. et al

    . Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997;104:1165–72

    PubMedWeb of Science
39. 39.↵
    1. Bartynski WS,
    2. Boardman JF

    . Catheter angiography, MR angiography and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2008;29:447–55

    Abstract/FREE Full Text
40. 40.↵
    1. Bartynski WS,
    2. Boardman JF

    . Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome (PRES). AJNR Am J Neuroradiol 2007;28:1320–27

    Abstract/FREE Full Text
41. 41.↵
    1. Wilasrusmee C,
    2. Da Silva M,
    3. Singh B,
    4. et al

    . Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction. Clin Transplant 2003;17:6–12

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Benigni A,
    2. Morigi M,
    3. Perico N,
    4. et al

    . The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 1992;54:775–80

    CrossRefPubMed
43. 43.↵
    1. Zoja C,
    2. Furci L,
    3. Ghilardi F,
    4. et al

    . Cyclosporin-induced endothelial cell injury. Lab Invest 1986;55:455–62

    PubMedWeb of Science